Table 2 |
||
|
Postprandial serum insulin area under the curve (AUC) in healthy subjects after the ingestion of OGTT with a placebo capsules (Reference) or the OGTT with C. longa capsules. |
||
|
Insulin AUC (mU min/L) |
||
|
|
||
|
Time |
Reference |
C. longa |
|
|
||
|
0-15 min |
169.2 ± 19.8 |
217.5 ± 37.7* |
|
0-30 min |
584.3 ± 61.2 |
838.1 ± 152.7* |
|
0-45 min |
1076.5 ± 111.4 |
1509.9 ± 252.2 |
|
0-60 min |
1521.7 ± 147.3 |
2021.0 ± 285.9 |
|
0-90 min |
2210.3 ± 215.5 |
2908.3 ± 353.0* |
|
0-120 min |
2749.5 ± 283.7 |
3570.9 ± 410.7* |
|
|
||
|
All values are means ± SEM, n = 14. Significant differences in serum insulin AUCs were evaluated with the Wilcoxon signed rank sum test. * = Significant difference between the responses to the OGTT with and without C. longa, P < 0.05. |
||
|
Wickenberg et al. Nutrition Journal 2010 9:43 doi:10.1186/1475-2891-9-43 |
||